A detailed history of Susquehanna International Group, LLP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Susquehanna International Group, LLP holds 195,927 shares of AMRN stock, worth $107,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares
195,927
Previous 105,495 85.72%
Holding current value
$107,759
Previous $72,000 70.83%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.57 - $0.8 $51,546 - $72,345
90,432 Added 85.72%
195,927 $123,000
Q2 2024

Aug 15, 2024

BUY
$0.63 - $1.07 $66,461 - $112,879
105,495 New
105,495 $72,000
Q4 2023

Feb 14, 2024

BUY
$0.66 - $0.91 $178,788 - $246,510
270,891 Added 67.0%
675,203 $587,000
Q3 2023

Nov 14, 2023

SELL
$0.85 - $1.43 $56,289 - $94,698
-66,223 Reduced 14.07%
404,312 $371,000
Q2 2023

Aug 11, 2023

BUY
$1.12 - $1.49 $165,943 - $220,764
148,164 Added 45.96%
470,535 $559,000
Q1 2023

May 16, 2023

SELL
$1.19 - $2.19 $840,405 - $1.55 Million
-706,223 Reduced 68.66%
322,371 $483,000
Q4 2022

Feb 14, 2023

SELL
$1.07 - $1.34 $519,737 - $650,886
-485,736 Reduced 32.08%
1,028,594 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$1.09 - $1.67 $284,757 - $436,279
261,245 Added 20.85%
1,514,330 $1.65 Million
Q2 2022

Aug 15, 2022

BUY
$1.13 - $3.69 $385,219 - $1.26 Million
340,902 Added 37.37%
1,253,085 $1.87 Million
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $2.12 Million - $2.77 Million
-743,731 Reduced 44.91%
912,183 $3 Million
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $413,035 - $660,346
-127,480 Reduced 7.15%
1,655,914 $5.58 Million
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $1.22 Million - $1.8 Million
-308,926 Reduced 14.76%
1,783,394 $9.1 Million
Q2 2021

Aug 11, 2021

SELL
$4.26 - $6.5 $4.42 Million - $6.75 Million
-1,038,277 Reduced 33.17%
2,092,320 $9.16 Million
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $1.64 Million - $2.88 Million
-327,032 Reduced 9.46%
3,130,597 $19.4 Million
Q4 2020

Feb 16, 2021

BUY
$4.04 - $5.31 $3 Million - $3.95 Million
743,317 Added 27.39%
3,457,629 $16.9 Million
Q3 2020

Nov 16, 2020

SELL
$3.64 - $7.76 $138,210 - $294,647
-37,970 Reduced 1.38%
2,714,312 $11.4 Million
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $7.45 Million - $12.9 Million
-1,559,107 Reduced 36.16%
2,752,282 $19 Million
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $1.04 Million - $5.61 Million
-260,338 Reduced 5.69%
4,311,389 $17.2 Million
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $13.8 Million - $23.9 Million
-990,075 Reduced 17.8%
4,571,727 $98 Million
Q3 2019

Nov 14, 2019

BUY
$13.89 - $23.16 $31.7 Million - $52.9 Million
2,283,058 Added 69.63%
5,561,802 $84.3 Million
Q2 2019

Aug 16, 2019

BUY
$16.27 - $20.51 $102,793 - $129,582
6,318 Added 0.19%
3,278,744 $63.6 Million
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $7.77 Million - $9.79 Million
-477,482 Reduced 12.73%
3,272,426 $63.5 Million
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $7.24 Million - $12.8 Million
574,054 Added 18.08%
3,749,908 $77.8 Million
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $153,908 - $284,997
-12,402 Reduced 0.39%
3,175,854 $43.2 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $3.58 Million - $23.8 Million
1,462,881 Added 84.79%
3,188,256 $51.9 Million
Q2 2018

Aug 14, 2018

SELL
$2.68 - $3.48 $743,204 - $965,056
-277,315 Reduced 13.85%
1,725,375 $5.33 Million
Q1 2018

May 15, 2018

BUY
$2.99 - $4.44 $4.59 Million - $6.81 Million
1,534,704 Added 327.94%
2,002,690 $6.03 Million
Q4 2017

Feb 14, 2018

BUY
$3.06 - $4.09 $286,777 - $383,306
93,718 Added 25.04%
467,986 $1.88 Million
Q3 2017

Nov 20, 2017

BUY
$3.03 - $3.72 $1.13 Million - $1.39 Million
374,268
374,268 $1.31 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.